Table 3. Backward regression models relating creatinine at baseline, creatinine at the 3-year follow-up study, and plasma PUFAs at baseline.
Creatinine at baseline | Creatinine at 3-years follow-up studya | |||
---|---|---|---|---|
β (SE) | P | β (SE) | P | |
Total plasma PUFAs, mg/L | −0.005 (0.002) | 0.06 | −0.005 (0.002) | 0.03 |
Plasma n-3 FA, mg/L | −0.02 (0.02) | 0.31 | −0.12 (0.03) | <0.0001 |
Plasma linolenic acid, mg/L | −0.002 (0.001) | 0.10 | −0.003 (0.001) | 0.002 |
Plasma n-6 FA, mg*10/L | −0.05 (0.02) | 0.03 | −0.04 (0.02) | 0.11 |
Plasma linoleic acid, mg*10/L | −0.001 (0.0005) | 0.07 | −0.001 (0.0006) | 0.01 |
Plasma arachidonic acid, mg*10/L | −0.0001 (0.001) | 0.95 | −0.002 (0.0006) | 0.003 |
Data adjusted for age, sex, BMI, education, cigarette smoking pack-years, MMSE score, energy intake, alcohol, LDL cholesterol, HDL cholesterol, self-reported cancer, cardiovascular disease, and hypertension. Covariates were selected using a Pearson correlation coefficient <0.10.
Also adjusted for creatinine at baseline.